Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (810)	9/15/1998 3:54:00 PM
From: Anthony Wong	Respond to of 1722

George, thanks for the excerpts. AHP (and MTC) have been on my watch list but I have "watched" too long and the stock price is now above my buy range. P.S. I know you're kidding, but believe me, I too feel there's an overkill on Viagra news.

To: aknahow who wrote (810)	9/15/1998 4:10:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 1722

09/15 16:00 Merck jumps on hopes for newer products NEW YORK, Sept 15 (Reuters) - Merck & Co <MRK.N> shares jumped Tuesday on top of sharp gains Monday after positive developments on important new medicines reduced worries over the impact of expiring U.S. patents on several older drugs, analysts said. Shares of Pfizer Inc <PFE.N>, meanwhile, slipped despite the decision Tuesday by the European Union to give marketing approval to its anti-impotence drug, Viagra. Analysts said investors were worried about signs that some European countries might sharply limit or totally deny reimbursement for Viagra, which became the fastest-selling drug in U.S. history after Pfizer launched it in May. Shares of Merck, which rose four on Monday, were up another 3-3/8 to 135-5/8. Pfizer was down 1-5/16 to 101-13/16.